Pharma & Biopharma

Two advances in (bio)pharmaceutical manufacture that aim to democratize the gift of medicine

David Duffy, Ulf Landegren, Antoine van Oijen, and Menno Prins crash through the concentration barrier and investigate the ultimate limit of analytical sensitivity.

Nearly half a century ago, J. Calvin Giddings published a letter that laid out his ideas for a new separation strategy. It resulted in a collection of techniques known as field-flow fractionation (FFF)

In some industries, for example, in early-stage pharmaceutical development, it is desirable to measure particle size from a small samples of dry powders. However measuring small quantities risks measuring a sample that is not representative of the bulk material. In this application note, we demonstrate the capability of the Aero S dry dispersion unit and the Mastersizer 3000 to measure small quantities of pharmaceutical materials dosed with large particles and to detect those large, anomalous particles.

As the world’s most populous country and the second largest global economy, the potential for growth is significant. But how does an analytical services company break into China?

This application note discusses the methodology and results for the rheological characterization of Opthalmic Viscosurgical Devices (OVDs) according to the International Standard ISO15798:2013

This technical note describes the system and explains how OMNISEC sets a new standard in molecular characterization.

This technical note describes the features and benefits of OMNISEC RESOLVE. It also includes a discussion of the value of OMNISEC as a complete system as opposed to upgrading an existing conventional system to advanced detection.

Michael Lämmerhofer opens up about his work on oxidative stress markers and the Chromatographic Society’s Jubilee Award.

We’re looking for analytical players for a new fixture on the calendar – Analytical Technologies Europe 2015. Together we can beat the challenges of the biopharmaceutical industry.